De Novo Truncating Mutations in WASF1 Cause Intellectual Disability with Seizures

  • Am J Hum Genet. 2018 Jul 5;103(1):144-153. doi: 10.1016/j.ajhg.2018.06.001.
Yoko Ito  1 ,  Keren J Carss  2 ,  Sofia T Duarte  3 ,  Taila Hartley  1 ,  Boris Keren  4 ,  Manju A Kurian  5 ,  Isabelle Marey  4 ,  Perinne Charles  4 ,  Carla Mendonça  6 ,  Caroline Nava  7 ,  Rolph Pfundt  8 ,  Alba Sanchis-Juan  2 ,  Hans van Bokhoven  8 ,  Anthony van Essen  9 ,  Conny van Ravenswaaij-Arts  9 ,  NIHR BioResource ,  Care4Rare Canada Consortium ,  Kym M Boycott  10 ,  Kristin D Kernohan  1 ,  Sarah Dyack  11 ,  F Lucy Raymond  12
Abstract

Next-generation Sequencing has been invaluable in the elucidation of the genetic etiology of many subtypes of intellectual disability in recent years. Here, using exome Sequencing and whole-genome Sequencing, we identified three de novo truncating mutations in WAS protein family member 1 (WASF1) in five unrelated individuals with moderate to profound intellectual disability with autistic features and seizures. WASF1, also known as WAVE1, is part of the WAVE complex and acts as a mediator between Rac-GTPase and Actin to induce Actin polymerization. The three mutations connected by Matchmaker Exchange were c.1516C>T (p.Arg506Ter), which occurs in three unrelated individuals, c.1558C>T (p.Gln520Ter), and c.1482delinsGCCAGG (p.Ile494MetfsTer23). All three variants are predicted to partially or fully disrupt the C-terminal actin-binding WCA domain. Functional studies using fibroblast cells from two affected individuals with the c.1516C>T mutation showed a truncated WASF1 and a defect in Actin remodeling. This study provides evidence that de novo heterozygous mutations in WASF1 cause a rare form of intellectual disability.

Keywords
WASF1; WAVE1 complex; actin cytoskeleton; autism; developmental delay; lamellipodia; neurodevelopmental disorder; recurrent de novo truncating mutations; seizures.